KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Cost of Revenue: 2009-2025

Historic Cost of Revenue for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to $735.0 million.

  • Bausch Health Companies' Cost of Revenue rose 7.77% to $735.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 billion, marking a year-over-year increase of 6.04%. This contributed to the annual value of $2.7 billion for FY2024, which is 8.34% up from last year.
  • Latest data reveals that Bausch Health Companies reported Cost of Revenue of $735.0 million as of Q3 2025, which was down 1.74% from $748.0 million recorded in Q2 2025.
  • In the past 5 years, Bausch Health Companies' Cost of Revenue registered a high of $748.0 million during Q2 2025, and its lowest value of $536.0 million during Q1 2022.
  • For the 3-year period, Bausch Health Companies' Cost of Revenue averaged around $674.0 million, with its median value being $683.0 million (2025).
  • In the last 5 years, Bausch Health Companies' Cost of Revenue rose by 25.31% in 2021 and then decreased by 5.96% in 2022.
  • Quarterly analysis of 5 years shows Bausch Health Companies' Cost of Revenue stood at $608.0 million in 2021, then rose by 5.10% to $639.0 million in 2022, then grew by 8.76% to $695.0 million in 2023, then climbed by 2.30% to $711.0 million in 2024, then grew by 7.77% to $735.0 million in 2025.
  • Its Cost of Revenue stands at $735.0 million for Q3 2025, versus $748.0 million for Q2 2025 and $683.0 million for Q1 2025.